Caricamento...
Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women
INTRODUCTION: In settings where HIV is prevalent in heterosexual population, pregnancy and postpartum breastfeeding periods can be associated with substantial HIV acquisition risk. Pre-exposure prophylaxis (PrEP) with daily oral tenofovir disoproxil fumarate (TDF)/emtricitabine is an attractive HIV...
Salvato in:
| Pubblicato in: | Expert Opin Drug Saf |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581312/ https://ncbi.nlm.nih.gov/pubmed/28571500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1338271 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|